Local insulin-like growth factor-II mediates prolactin-induced mammary gland development.

Prolactin (PRL) is a major determinant of mammary epithelial cell proliferation during alveolar development in sexually mature and pregnant mice. To date, it has not been clear whether PRL effects these responses alone or by also invoking the action of autocrine/paracrine growth factors. In this study, we provide evidence that part of the effect of PRL on mammary gland growth is mediated by IGF-II. During sexual maturity and in early pregnancy, the level of IGF-II mRNA in the mammary gland was increased concurrent with increased PRL receptor expression. The level of IGF-II mRNA was reduced in mammary tissue from PRL receptor-/- mice during early pregnancy, and explants of mouse mammary gland and HC11 mammary epithelial cells both increased their expression of IGF-II after exposure to PRL in vitro. These findings coincided with the demonstration that IGF-II stimulated alveolar development in mammary glands in whole organ culture. PRL was most efficacious in stimulating IGF-II gene transcription from promoter 3 of the mouse IGF-II gene in vitro. Insight into the mechanism by which PRL induced IGF-II expression was provided by the fact that it was blocked by the Jak2 inhibitor AG490 and the MAPK inhibitor PD98059. Finally, induction of insulin receptor substrate (IRS)-1 in the mammary glands of PRL-treated mice and induction of IRS-1 and IRS-2 after treatment with PRL plus progesterone indicates that these molecules are induced by PRL as potential signaling intermediates downstream from IGF-I/insulin receptors. Together, these data demonstrate a role for IGF-II as a mediator of PRL action in the mouse mammary gland during ductal branching and alveolar development.

[1]  T. Wood,et al.  The Insulin-Like Growth Factors (IGF) and IGF Type I Receptor during Postnatal Growth of the Murine Mammary Gland: Sites of Messenger Ribonucleic Acid Expression and Potential Functions* * This work was supported, in part, by NIH Grant DK-48103 (to T.L.W.). , 1999, Endocrinology.

[2]  M. Brandon,et al.  Developmental and tissue-specific regulation of ovine insulin-like growth factor II (IGF-II) mRNA expression , 1991, Molecular and Cellular Endocrinology.

[3]  D. Flint,et al.  Interactions of Prolactin and Growth Hormone (GH) in the Regulation of Mammary Gland Function and Epithelial Cell Survival , 2004, Journal of Mammary Gland Biology and Neoplasia.

[4]  R. Weinberg,et al.  Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. , 2000, Genes & development.

[5]  S. Hamamoto,et al.  Stimulation of mammary epithelial cell growth in vitro: interaction of epidermal growth factor and mammogenic hormones. , 1985, Endocrinology.

[6]  A. Costantino,et al.  Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism , 1999, Oncogene.

[7]  B. Vonderhaar,et al.  Activation ofraf-1, MEK, and MAP kinase in prolactin responsive mammary cells , 2005, Breast Cancer Research and Treatment.

[8]  Alastair,et al.  Developmental regulation of insulin-like growth factor II mRNA in different rat tissues. , 1986, The Journal of biological chemistry.

[9]  H. Shih,et al.  Metabolic regulation of hepatic gene expression. , 1996, Biochemical Society transactions.

[10]  A. Costantino,et al.  Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells , 1999, Molecular and Cellular Biology.

[11]  M. Yoder,et al.  Differential expression of insulin-like growth factor binding proteins in murine hematopoietic stromal cell lines , 1996, Molecular and Cellular Endocrinology.

[12]  R. Hovey,et al.  Regulation of Mammary Gland Growth and Morphogenesis by the Mammary Fat Pad: A Species Comparison , 2004, Journal of Mammary Gland Biology and Neoplasia.

[13]  W. Ruan,et al.  IGF-I: An Essential Factor in Terminal End Bud Formation and Ductal Morphogenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.

[14]  I. Forsyth,et al.  The mammary gland. , 1991, Bailliere's clinical endocrinology and metabolism.

[15]  P. Rotwein,et al.  Evolution of insulin-like growth factor II: characterization of the mouse IGF-II gene and identification of two pseudo-exons. , 1990, DNA and Cell Biology.

[16]  B. Vonderhaar,et al.  Hormonal regulation of milk protein gene expression. , 1989, Annual review of physiology.

[17]  B. Vonderhaar,et al.  Role of growth hormone and insulin-like growth factor-I in mammary development. , 1993, Endocrinology.

[18]  H. Werner,et al.  The role of the insulin-like growth factor system in human cancer. , 1996, Advances in cancer research.

[19]  T. Riss,et al.  Growth and continuous passage of COMMA-D mouse mammary epithelial cells in hormonally defined serum-free medium. , 1987, Cancer research.

[20]  R. Weinberg,et al.  Prolactin controls mammary gland development via direct and indirect mechanisms. , 1999, Developmental biology.

[21]  G. Stark,et al.  Regulation of STAT‐dependent pathways by growth factors and cytokines , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  D. Campani,et al.  IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: Anin situ hybridization and immunohistochemistry study , 2005, Breast Cancer Research and Treatment.

[23]  D. Hill,et al.  Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) , 1995, British Journal of Cancer.

[24]  N. Horseman.  Prolactin and Mammary Gland Development , 2004, Journal of Mammary Gland Biology and Neoplasia.

[25]  M. Cáceres,et al.  Src family kinases are required for prolactin induction of cell proliferation. , 2001, Molecular biology of the cell.

[26]  D. L. Dorr,et al.  Determining the stage of the estrous cycle in the mouse by the appearance of the vagina. , 1973, Biology of reproduction.

[27]  L. Faulkin,et al.  Regulation of growth and spacing of gland elements in the mammary fat pad of the C3H mouse. , 1960, Journal of the National Cancer Institute.

[28]  R. Hovey,et al.  Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[29]  R. Rugh,et al.  The mouse; its reproduction and development , 1968 .

[30]  F. Nielsen.  The molecular and cellular biology of insulin-like growth factor II. , 1992, Progress in growth factor research.

[31]  J. Fata,et al.  Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice , 2001, Cell Death and Differentiation.

[32]  B. Vonderhaar,et al.  Prolactin synthesis and secretion by human breast cancer cells. , 1995, Cancer research.

[33]  W. Engström,et al.  Regulation of a promoter from the mouse insulin like growth factor II gene by glucocorticoids , 1997, FEBS letters.

[34]  D. Clemmons,et al.  The direct in vitro effect of insulin-like growth factors (IGFs) on normal bovine mammary cell proliferation and production of IGF binding proteins. , 1991, Endocrinology.

[35]  A. Ullrich,et al.  Tissue-specific and developmentally regulated transcription of the insulin-like growth factor 2 gene. , 1987, DNA.

[36]  Á. Pascual-Leone,et al.  Effect of thyroxine administration on the IGF/IGF binding protein system in neonatal and adult thyroidectomized rats. , 2001, The Journal of endocrinology.

[37]  B. Groner,et al.  Lactogenic Hormone Activation of Stat5 and Transcription of the β-Casein Gene in Mammary Epithelial Cells Is Independent of p42 ERK2 Mitogen-activated Protein Kinase Activity* , 1996, The Journal of Biological Chemistry.

[38]  R. Hovey,et al.  Ontogeny and epithelial–stromal interactions regulate IGF expression in the ovine mammary gland , 1998, Molecular and Cellular Endocrinology.

[39]  R. Vigneri,et al.  Regulation of the Akt/Glycogen synthase kinase‐3 axis by insulin‐like growth factor‐II via activation of the human insulin receptor isoform‐A , 2001, Journal of cellular biochemistry.

[40]  T. Hunter,et al.  JAK2, Ras, and Raf Are Required for Activation of Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase by Growth Hormone (*) , 1995, The Journal of Biological Chemistry.

[41]  P. Kelly,et al.  Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. , 1997, Genes & development.

[42]  P. Darbre,et al.  Overexpression of insulin-like growth factor II in human breast cancer cells. , 1996, Biochemical Society transactions.

[43]  I. Forsyth,et al.  Stimulation of DNA synthesis in cultures of ovine mammary epithelial cells by insulin and insulin-like growth factors. , 1989, The Journal of endocrinology.

[44]  F. Talamantes,et al.  Expression of a lactogen-dependent insulin-like growth factor-binding protein in cultured mouse mammary epithelial cells. , 1992, Endocrinology.

[45]  R. Derynck,et al.  Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production. , 1987, Molecular endocrinology.

[46]  N. Hynes,et al.  The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells. , 2001, Molecular endocrinology.

[47]  H. Huynh,et al.  Pregnancy-dependent growth of mammary tumors is associated with overexpression of insulin-like growth factor II. , 1996, Cancer research.

[48]  S. Nandi,et al.  Regulation of mammary epithelial cell growth in mice and rats. , 1990, Endocrine reviews.